1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porters Fiver Forces Analysis 39
3 Segmentation of Asia Pacific Market by Product 43
3.1 Market Overview by Product 43
3.2 Instruments & Devices 45
3.2.1 Disposable IVD Devices 46
3.2.2 Reusable IVD Devices 47
3.3 Reagents & Kits 48
3.4 Software & Services 49
4 Segmentation of Asia Pacific Market by Technology 50
4.1 Market Overview by Technology 50
4.2 Clinical Chemistry 52
4.3 Molecular Diagnostics 53
4.4 Immuno Diagnostics 54
4.5 Hematology 55
4.6 Tissue Diagnostics 56
4.7 Microbiology 57
4.8 Coagulation and Hemostasis 58
4.9 Urinalysis 59
4.10 Other Technologies 60
5 Segmentation of Asia Pacific Market by Sample Type 61
5.1 Market Overview by Sample Type 61
5.2 Blood 63
5.3 Mucus 64
5.4 Urine 65
5.5 Other Sample Types 66
6 Segmentation of Asia Pacific Market by Application 67
6.1 Market Overview by Application 67
6.2 Infectious Diseases 69
6.3 Diabetes 79
6.4 Cancer/Oncology 80
6.5 Cardiology 81
6.6 Autoimmune Disease 82
6.7 Nephrology 83
6.8 Drug Testing 84
6.9 HIV/AIDS 85
6.10 Other Applications 86
7 Segmentation of Asia Pacific Market by End User 87
7.1 Market Overview by End User 87
7.2 Diagnostic Laboratories 89
7.3 Hospitals and Clinics 90
7.4 Homecare Settings 91
7.5 Point-of-Care (POC) Settings 92
7.6 Other End Users 93
8 Asia-Pacific Market 2021-2031 by Country 94
8.1 Overview of Asia-Pacific Market 94
8.2 Japan 97
8.3 China 100
8.4 Australia 102
8.5 India 104
8.6 South Korea 106
8.7 Rest of APAC Region 108
9 Competitive Landscape 110
9.1 Overview of Key Vendors 110
9.2 New Product Launch, Partnership, Investment, and M&A 113
9.3 Company Profiles 114
Abbott Laboratories, Inc. 114
Agilent Technologies, Inc. 116
Arkray Inc. 117
Becton, Dickinson and Company 118
Biomerieux SA 119
Bio-Rad Laboratories Inc. 120
Danaher Corporation 121
DiaSorin SpA (Luminex Corporation) 122
Epic Systems Corporation 123
F. Hoffmann-La Roche Ltd. 124
Genpact Limited 125
Grifols SA 126
IBM Corporation 127
Mckesson Corporation 128
Ortho Clinical Diagnostics Inc. 129
Qiagen NV 130
Quest Diagnostics Inc. 131
Quidel Corporation 132
Roche Diagnostics 133
Siemens Healthineers 134
Sysmex Corporation 135
Thermo Fisher Scientific Inc. 136
RELATED REPORTS 137